Convening Notice of 7th Annual General Meeting

Pursuant to Article 365 of the Korean Commercial Act and Article 21 of the Articles of Incorporation of the Company, SCAI Therapeutics Co., Ltd. hereby announces that the 7th Annual General Meeting of Shareholders for the fiscal year January 1, 2025 – December 31, 2025 will be held as follows. Your attendance is kindly requested.

Details of the Meeting

1. Date and Time:
   Monday, March 30, 2026, at 10:00 a.m.

2. Venue:
   Conference Room #203, Building A, Daedeok Biz Center, 17 Techno 4-ro, Yuseong-gu, Daejeon, Republic of Korea

3. Agenda:

a. Reports:

• Business Report

• Audit Report

b. Proposals for Resolution:

1. Approval of the Financial Statements for the 7th Fiscal Year

2. Appointment of Inside Director

3. Appointment of Outside Directors

4. Approval of the Remuneration Limit for Directors

5. Approval of the Remuneration Limit for Auditors

6. Amendment of the Articles of Incorporation

7. Extension of the Exercise Period for Stock Options

8. Approval of the Granting of Stock Options

c.Exercise of Voting Rights:

Shareholders may exercise their voting rights either in person at the meeting or by proxy in accordance with the power of attorney.

March 13, 2026
SCAI Therapeutics Co., Ltd.
Chief Executive Officer: Chul hwan Kim